Conceptus, Inc. ( CPTS) Announces Dates of 18th Annual Congress of the European Society for Gynecologic Endoscopy

Conceptus, Inc. (Nasdaq: CPTS), the company that developed the Essure ® procedure, the very first non-incisional permanent birth control method proven efficacy, announced that at 18th Annual Congress of the European Society for Gynecologic Endoscopy (European Society for Gynecological Endoscopy, ESGE), to be held in Florence, Italy, October 28 to 31 next, will be emphasized to the clinical success of the procedure Essure ®.

The accepted 12 ESGE compendiums devoted to Essure ® procedure, which will be presented by speakers from across Europe who recognize this procedure as the reference standard for sterilization hysteroscopy.


There are 0 comments
Please note that comments may take up to one hour before they get published on the site. Please check back later to see your comments.

Post new comment

The content of this field is kept private and will not be shown publicly.